Evidence map›Paper›PMID 31861384›Full record

ArticleMolecules (Basel, Switzerland)2019

Multifloroside Suppressing Proliferation and Colony Formation, Inducing S Cell Cycle Arrest, ROS Production, and Increasing MMP in Human Epidermoid Carcinoma Cell Lines A431.

Xin Zhang, Yamei Li, Zhengping Feng, Yaling Zhang, Ye Gong, Huanhuan Song, Xiaoli Ding, Yaping Yan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xin ZhangNational Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest of China, College of Life Science, Shaanxi Normal University, Xi'an 710062, China.
Yamei LiNational Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest of China, College of Life Science, Shaanxi Normal University, Xi'an 710062, China.
Zhengping FengNational Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest of China, College of Life Science, Shaanxi Normal University, Xi'an 710062, China.
Yaling ZhangNational Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest of China, College of Life Science, Shaanxi Normal University, Xi'an 710062, China.
Ye GongNational Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest of China, College of Life Science, Shaanxi Normal University, Xi'an 710062, China.
Huanhuan SongNational Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest of China, College of Life Science, Shaanxi Normal University, Xi'an 710062, China.
Xiaoli DingNational Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest of China, College of Life Science, Shaanxi Normal University, Xi'an 710062, China.
Yaping YanNational Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest of China, College of Life Science, Shaanxi Normal University, Xi'an 710062, China.

Funding

the Fundamental Research Funds for the Central Universities GK201906010, GK201701009 and GK201603110the National Natural Science Foundation of China 81571596, 81601044 and 81771279
6 · The paper itself

Abstract

Multifloroside (

Indexed as

Antineoplastic Agents, PhytogenicApoptosisCarcinoma, Squamous CellCell Cycle CheckpointsCell Line, TumorCell ProliferationCell SurvivalHumansIridoidsMatrix MetalloproteinasesMolecular StructureReactive Oxygen SpeciesSignal TransductionStructure-Activity RelationshipAntineoplastic Agents, PhytogenicIridoidsMatrix MetalloproteinasesReactive Oxygen Species10-oxyderivatives of oleoside secoiridoidsanti-cancer activitiesflow cytometrymultiflorosidestructure-activity relationship

Identifiers

PMID31861384
PMCPMC6983163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.